{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:04:05Z","timestamp":1787069045750,"version":"build-2736575974"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Juvenile-onset systemic lupus erythematosus (JSLE) is a chronic autoimmune disease affecting individuals under 18, causing multi-system impairment. Patients with JSLE exhibit more severe disease when compared to patients with adult-onset SLE. This study aimed to evaluate the prevalence of endocrine and metabolic comorbidities in patients with JSLE, and analyze the factors associated with each comorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Anthropometric, clinical, laboratory data, and the details of glucocorticoids and disease-modifying anti-rheumatic drugs use were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 57 patients with JSLE (48 girls and 9 boys) were included in this study. Endocrine and metabolic comorbidities were observed in 64.9% of the patients. The most prevalent comorbidities were dyslipidemia (40.4%), being overweight or obese (26.3%), subclinical hypothyroidism (24.6%), autoimmune thyroid disease (AITD) (21.1%), and low bone mass (20.9%). The risk of dyslipidemia and AITD increased in patients who were overweight or obese. The risk of being overweight or obese was associated with skin involvement at diagnosis and rheumatoid factor positivity. Younger age at diagnosis and longer duration of glucocorticoid exposure increased the risk of low bone mass. The overall prevalence of endocrine and metabolic comorbidities was associated with short stature at diagnosis, being overweight or obese at follow-up, skin involvement at diagnosis, and rheumatoid factor positivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with JSLE have higher burdens of endocrine and metabolic comorbidities and should be routinely monitored. Prevention of obesity may be helpful in lowering the risk of comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1429337","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T02:10:01Z","timestamp":1738807801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus"],"prefix":"10.3389","volume":"12","author":[{"given":"Su Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Bae","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Chul","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic Lupus erythematosus.","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/acr.21757","article-title":"Taxonomy for systemic Lupus erythematosus with onset before adulthood.","volume":"64","author":"Silva","year":"2012","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0961203320909156","article-title":"Clinical and laboratory characteristics in juvenile-onset systemic Lupus erythematosus across age groups.","volume":"29","author":"Massias","year":"2020","journal-title":"Lupus."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1136\/annrheumdis-2017-211663","article-title":"Survival in adults and children with systemic Lupus erythematosus: A systematic review and bayesian meta-analysis of studies from 1950 to 2016.","volume":"76","author":"Tektonidou","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00144","article-title":"Pediatric systemic Lupus erythematosus: Learning from longer follow up to adulthood.","volume":"6","author":"Costagliola","year":"2018","journal-title":"Front Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40744-016-0044-0","article-title":"An update on treatment and management of pediatric systemic Lupus erythematosus.","volume":"3","author":"Thakral","year":"2016","journal-title":"Rheumatol Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 Update of the eular recommendations for the management of systemic Lupus erythematosus.","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.clinthera.2013.03.001","article-title":"Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic Lupus erythematosus.","volume":"35","author":"Shah","year":"2013","journal-title":"Clin Therapeutics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/ITT.S377076","article-title":"Managing cardiovascular risk in systemic Lupus erythematosus: Considerations for the clinician.","volume":"12","author":"Semalulu","year":"2023","journal-title":"Immunotargets Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00431-020-03910-2","article-title":"Longitudinal growth patterns and final height in childhood-onset systemic Lupus erythematosus.","volume":"180","author":"Jongvilaikasem","year":"2021","journal-title":"Eur J Pediatrics."},{"key":"B11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/annrheumdis-2011-200106","article-title":"A longitudinal printo study on growth and puberty in juvenile systemic Lupus erythematosus.","volume":"71","author":"Rygg","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s10067-015-3011-1","article-title":"Bone mineral density reduction in adolescents with systemic erythematosus lupus: Association with lack of Vitamin D supplementation.","volume":"34","author":"Caetano","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6065\/apem.2346060.030","article-title":"Factors affecting bone mineral density in children and adolescents with systemic Lupus erythematosus.","volume":"29","author":"Park","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.autrev.2018.11.006","article-title":"Juvenile polyautoimmunity in a rheumatology setting.","volume":"18","author":"Malagon","year":"2019","journal-title":"Autoimmun Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.04809.x","article-title":"Autoimmune thyroid disease and autoimmune rheumatic disorders: A two-sided analysis.","volume":"1173","author":"Lazurova","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"B16","first-page":"81","article-title":"Thyroid disorders and autoantibodies in systemic Lupus erythematosus and rheumatoid arthritis patients.","volume":"11","author":"El-Sherif","year":"2004","journal-title":"Egypt J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3390\/medicina59111911","article-title":"Thyroid disease and systemic Lupus erythematosus.","volume":"59","author":"Athanassiou","year":"2023","journal-title":"Medicina (Kaunas)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00296-010-1556-5","article-title":"The spectrum of thyroid disorders in systemic Lupus erythematosus.","volume":"32","author":"Kumar","year":"2012","journal-title":"Rheumatol Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.autrev.2018.03.009","article-title":"Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: A Brazilian multicenter study.","volume":"17","author":"Setoue","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/rheumatology\/keh531","article-title":"Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis.","volume":"44","author":"Stagi","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic Lupus erythematosus.","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European league against Rheumatism\/American college of rheumatology classification criteria for systemic Lupus erythematosus.","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheumatic Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic Lupus international collaborating clinics classification criteria for systemic Lupus erythematosus.","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/0961203314555537","article-title":"Effects of obesity on health-related quality of life in juvenile-onset systemic Lupus erythematosus.","volume":"24","author":"Mina","year":"2015","journal-title":"Lupus."},{"key":"B25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4","article-title":"The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.","volume":"42","year":"1999","journal-title":"Arthritis Rheumatism."},{"key":"B26","first-page":"288","article-title":"Systemic Lupus erythematosus disease activity index 2000.","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102615","article-title":"Clinical disease activity and flare in Sle: Current concepts and novel biomarkers.","volume":"119","author":"Thanou","year":"2021","journal-title":"J Autoimmun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3345\/kjp.2018.61.5.135","article-title":"The 2017 Korean national growth charts for children and adolescents: Development, improvement, and prospects.","volume":"61","author":"Kim","year":"2018","journal-title":"Korean J Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6065\/apem.2040064.032","article-title":"Deciphering short stature in children.","volume":"25","author":"Polidori","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"B30","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes\u20142011.","volume":"34","year":"2011","journal-title":"Diabetes Care."},{"key":"B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00774-013-0488-z","article-title":"Reference values for bone mineral density according to age with body size adjustment in Korean children and adolescents.","volume":"32","author":"Yi","year":"2014","journal-title":"J Bone Miner Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6065\/apem.2244060.030","article-title":"Clinical practice guidelines for optimizing bone health in Korean children and adolescents.","volume":"27","author":"Lee","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/EJE-20-1487","article-title":"Management of endocrine disease: Diagnosis and management of primary amenorrhea and female delayed puberty.","volume":"184","author":"Seppa","year":"2021","journal-title":"Eur J Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency.","volume":"3","author":"Bancos","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline.","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1210\/clinem\/dgac492","article-title":"Approach to the patient: Diagnosis of cushing syndrome.","volume":"107","author":"Savas","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The British society for rheumatology guideline for the management of systemic Lupus erythematosus in adults.","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1210\/jc.2009-1180","article-title":"Association of serum Tsh with high body mass differs between smokers and never-smokers.","volume":"94","author":"A\u00b0svold","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000351076","article-title":"Dyslipidemia in pediatric systemic Lupus erythematosus: The relationship with disease activity and plasma homocysteine and cysteine concentrations.","volume":"63","author":"Ortiz","year":"2013","journal-title":"Ann Nutr Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00296-015-3393-z","article-title":"Lipid profile among girls with systemic Lupus erythematosus.","volume":"37","author":"Machado","year":"2017","journal-title":"Rheumatol. Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0961203307079566","article-title":"Review: Management of dyslipidemia in children and adolescents with systemic Lupus erythematosus.","volume":"16","author":"Ardoin","year":"2007","journal-title":"Lupus."},{"key":"B42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3803\/EnM.2012.27.3.208","article-title":"Lipid profiles and prevalence of dyslipidemia in Korean adolescents.","volume":"27","author":"Kim","year":"2012","journal-title":"Endocrinol. Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1002\/art.20630","article-title":"Anti-lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic Lupus erythematosus?","volume":"50","author":"de Carvalho","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e210002","DOI":"10.1530\/ec-21-0002","article-title":"Update on dyslipidemia in hypothyroidism: The mechanism of dyslipidemia in hypothyroidism.","volume":"11","author":"Liu","year":"2022","journal-title":"Endocr Connect."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/children10101618","article-title":"Factors affecting dyslipidemia among Korean adolescents: An analysis using the 8th korea national health and nutrition examination survey (2021).","volume":"10","author":"Choe","year":"2023","journal-title":"Children (Basel)."},{"key":"B46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.6065\/apem.2142230.115","article-title":"Cardiometabolic risk factors and metabolic syndrome based on severity of obesity in Korean children and adolescents: Data from the Korea national health and nutrition examination survey 2007\u20132018.","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7570\/jomes20002","article-title":"Secular trends in pediatric overweight and obesity in Korea.","volume":"29","author":"Kim","year":"2020","journal-title":"Jomes."},{"key":"B48","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.3390\/ijms21238985","article-title":"Obesity-related changes in high-density lipoprotein metabolism and function.","volume":"21","author":"Stadler","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/17402520600876945","article-title":"Mechanisms of dyslipoproteinemias in systemic Lupus erythematosus.","volume":"13","author":"Borba","year":"2006","journal-title":"Clin Dev Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/art.21748","article-title":"The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic Lupus erythematosus.","volume":"54","author":"Sarkissian","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/art.22332","article-title":"Longitudinal examination of lipid profiles in pediatric systemic Lupus erythematosus.","volume":"56","author":"Sarkissian","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B52","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/art.1780310706","article-title":"Dyslipoproteinemia in pediatric systemic Lupus erythematosus.","volume":"31","author":"Ilowite","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1210\/jc.2009-2798","article-title":"Investigations of thyroid hormones and antibodies in obesity: Leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants.","volume":"95","author":"Marzullo","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12902-022-00981-0","article-title":"Obesity is associated with subclinical hypothyroidism in the presence of thyroid autoantibodies: A cross-sectional study.","volume":"22","author":"Yan","year":"2022","journal-title":"BMC Endocrine Disorders."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1210\/jc.2010-1245","article-title":"Thyroid and obesity: An intriguing relationship.","volume":"95","author":"Biondi","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B56","first-page":"421","article-title":"Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia.","volume":"62","author":"Tamer","year":"2011","journal-title":"Endokrynol. Polska"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6874395","article-title":"Thyroid function in Korean adolescents with obesity: Results from the Korea national health and nutrition examination survey Vi (2013\u20132015).","volume":"2018","author":"Cho","year":"2018","journal-title":"Int J Endocrinol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1177\/0961203318759607","article-title":"The lupus patient with positive rheumatoid factor.","volume":"27","author":"Fedrigo","year":"2018","journal-title":"Lupus"},{"key":"B59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic Lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic Lupus erythematosus.","volume":"72","author":"Cervera","year":"1993","journal-title":"Medicine (Baltimore)."},{"key":"B60","doi-asserted-by":"publisher","first-page":"A54","DOI":"10.1136\/lupus-2019-lsm.73","article-title":"73 Rheumatoid factor in patients with systemic Lupus erythematosus.","volume":"6","author":"Garate","year":"2019","journal-title":"Lupus Sci. Med."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-13-1","article-title":"Mucocutaneous manifestations in juvenile-onset systemic Lupus erythematosus: A review of literature.","volume":"13","author":"Chiewchengchol","year":"2015","journal-title":"Pediatr Rheumatol Online J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000013304","article-title":"Serological markers of autoimmunity in renal transplant patients with chronic Hepatitis C.","volume":"18","author":"Rostaing","year":"1998","journal-title":"Am J Nephrol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00296-022-05238-6","article-title":"Obesity as a comorbidity in children and adolescents with autoimmune rheumatic diseases.","volume":"43","author":"Held","year":"2023","journal-title":"Rheumatol Int."},{"key":"B64","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: Not a passive bystander.","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmunity Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13679-020-00397-8","article-title":"Autoantibody production in obesity: Is there evidence for a link between obesity and autoimmunity?","volume":"9","author":"Tsigalou","year":"2020","journal-title":"Curr Obesity Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1002\/art.27629","article-title":"Abdominal adiposity in rheumatoid arthritis: Association with cardiometabolic risk factors and disease characteristics.","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheumatism."},{"key":"B67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.2007.077578","article-title":"Visfatin (Pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis.","volume":"67","author":"Matsui","year":"2008","journal-title":"Ann Rheumatic Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3899\/jrheum.160214","article-title":"Cumulative burden of glucocorticoid-related adverse events in patients with systemic Lupus erythematosus: Findings from a 12-year longitudinal study.","volume":"45","author":"Chen","year":"2018","journal-title":"J Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/096120339300200109","article-title":"Autoimmune thyroid disorders in sle in Singapore.","volume":"2","author":"Boey","year":"1993","journal-title":"Lupus."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00138","article-title":"Systemic Lupus erythematosus and thyroid autoimmunity.","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8894792","article-title":"The association of obesity with autoimmune thyroiditis and thyroid function-possible mechanisms of bilateral interaction.","volume":"2020","author":"Baranowska-Bik","year":"2020","journal-title":"Int J Endocrinol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4216","article-title":"Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.","volume":"6","author":"Chen","year":"2018","journal-title":"PeerJ."},{"key":"B73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/03009749309099263","article-title":"Autoimmune thyroid disorders in seropositive versus seronegative rheumatoid arthritis.","volume":"1","author":"Ghitany","year":"2015","journal-title":"Egyptian J Obesity Diabetes Endocrinol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/RHU.0b013e31819dbe4c","article-title":"Prevalence of thyroid dysfunction in systemic Lupus erythematosus.","volume":"15","author":"Appenzeller","year":"2009","journal-title":"J Clin Rheumatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/1529-0131(199905)42:5","article-title":"Frequency of fractures in women with systemic Lupus erythematosus: Comparison with United States population data.","volume":"42","author":"Ramsey-Goldman","year":"1999","journal-title":"Arthritis Rheumatism."},{"key":"B76","first-page":"1666","article-title":"Fractures in rheumatoid arthritis: An evaluation of associated risk factors.","volume":"20","author":"Michel","year":"1993","journal-title":"J Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00198-003-1548-3","article-title":"Oral glucocorticoid use is associated with an increased risk of fracture.","volume":"15","author":"Steinbuch","year":"2004","journal-title":"Osteoporosis Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-019-0667-1","article-title":"A meta-analysis of secondary osteoporosis in systemic Lupus erythematosus: Prevalence and risk factors.","volume":"15","author":"Gu","year":"2019","journal-title":"Arch Osteoporos."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: Pathophysiology and therapy.","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporosis Int."},{"key":"B80","article-title":"Effects of glucocorticoids on the growth plate.","author":"Lui","year":"2010","journal-title":"Pediatric Adrenal Dis. Workshop Turin, May 2010."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1210\/jcem.83.8.5036","article-title":"Treatment of glucocorticoid-induced growth suppression with growth hormone. National cooperative growth study.","volume":"83","author":"Allen","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/rheumatology\/kep067","article-title":"Influence of age at disease onset in the outcome of paediatric systemic Lupus erythematosus.","volume":"48","author":"Descloux","year":"2009","journal-title":"Rheumatology (Oxford)."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10067-008-0887-z","article-title":"Influence of gender and age of onset on the outcome in children with systemic Lupus erythematosus.","volume":"27","author":"Al-Mayouf","year":"2008","journal-title":"Clin Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/0961203307080636","article-title":"Distinctive clinical features of pediatric systemic Lupus erythematosus in three different age classes.","volume":"16","author":"Pluchinotta","year":"2007","journal-title":"Lupus."},{"key":"B85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5001\/omj.2017.56","article-title":"Growth pattern in children with systemic Lupus erythematosus.","volume":"32","author":"Abdalla","year":"2017","journal-title":"Oman Med J."},{"key":"B86","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","article-title":"Thyroid diseases and bone health.","volume":"41","author":"Williams","year":"2018","journal-title":"J Endocrinol Investigation."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: A consensus statement.","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B88","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12969-023-00923-7","article-title":"Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases.","volume":"21","author":"Taman","year":"2023","journal-title":"Pediatr Rheumatol Online J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12969-021-00528-y","article-title":"A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases.","volume":"19","author":"de Gruijter","year":"2021","journal-title":"Pediatr Rheumatol Online J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0961203308094652","article-title":"Menstrual and hormonal alterations in juvenile systemic Lupus erythematosus.","volume":"18","author":"Medeiros","year":"2009","journal-title":"Lupus."},{"key":"B91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1191\/0961203306lu2291oa","article-title":"Disease outcomes and ovarian function of childhood-onset systemic Lupus erythematosus.","volume":"15","author":"Brunner","year":"2006","journal-title":"Lupus."},{"key":"B92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/03009742.2014.908237","article-title":"Ovarian reserve in adult patients with childhood-onset Lupus: A possible deleterious effect of methotrexate?","volume":"43","author":"de Araujo","year":"2014","journal-title":"Scand J Rheumatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/0961203307079300","article-title":"Risk factors for amenorrhea in juvenile systemic Lupus Erythematosus (Jsle): A Brazilian multicentre cohort study.","volume":"16","author":"Silva","year":"2007","journal-title":"Lupus."},{"key":"B94","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2005.01.013","article-title":"Exogenous Cushing\u2019s syndrome and glucocorticoid withdrawal.","volume":"34","author":"Hopkins","year":"2005","journal-title":"Endocrinol Metab Clinics."},{"key":"B95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/endocrines1020012","article-title":"Steroid-induced iatrogenic adrenal insufficiency in children: A literature review.","volume":"1","author":"Akahoshi","year":"2020","journal-title":"Endocrines."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5750791","article-title":"Glucocorticoid withdrawal symptoms and quality of life in patients with systemic Lupus erythematosus.","volume":"2023","author":"Karoonkatima","year":"2023","journal-title":"Int J Rheumatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/j.1651-2227.2010.01936.x","article-title":"Adrenal insufficiency after glucocorticoid withdrawal in children with Rheumatic diseases.","volume":"99","author":"Huber","year":"2010","journal-title":"Acta Paediatr."},{"key":"B98","first-page":"126","article-title":"Organ-specific autoantibodies and autoimmune diseases in juvenile systemic Lupus Erythematosus and juvenile dermatomyositis patients.","volume":"30","author":"Aikawa","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpam.2016.04.002","article-title":"Coexistence of endocrinopathies in children with rheumatic diseases.","volume":"3","author":"Alhomaidah","year":"2016","journal-title":"Int J Pediatr Adolesc Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e32520","DOI":"10.1097\/md.0000000000032520","article-title":"Increased risk of type 2 diabetes in patients with systemic Lupus erythematosus: A nationwide cohort study in Taiwan.","volume":"101","author":"Lin","year":"2022","journal-title":"Medicine (Baltimore)."},{"key":"B101","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1871530322666220908154253","article-title":"Insulin resistance and diabetes mellitus in patients with systemic Lupus erythematosus.","volume":"23","author":"Garc\u00eda-Carrasco","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1429337\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T02:10:09Z","timestamp":1738807809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1429337\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":101,"alternative-id":["10.3389\/fmed.2025.1429337"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1429337","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1429337"}}